FLUID BED TECHNOLOGY: OVERVIEW AND PARAMETERS FOR PROCESS SELECTION
Abstract
Formulation development is the most emerging and upcoming face of pharmaceutical technology in the current era. It is contemporarily capturing the market leaps and bounds with recent trends and developments with its innovative techniques. The day-to-day advancements in the research have provided an edge to this brilliant branch of pharmaceutical sector for not only uplifting the pharmacy profession but also to conquer the diseased state for nurturing the health and humanity. The fluid-bed technology or air-suspension process is the potential tool to develop newer trends and implications in the sector of formulation development with maximum therapeutic efficacy. The technology is used for granulation/agglomeration, layering and coating of a wide range of particle size. In addition; the technique can be used for the drying process as well. The three patterns of the fluid-bed processes could be characterized by the position/location of the spray nozzle i.e. top spray, bottom spray or tangential spray. This article reviews the three techniques with some innovative fluid bed pelletizing technologies like CPS™, MicroPx™, ProCell™ and discusses their applications, advantages and limitations. These advanced pelletizing technologies are recentely added to complement the actual capabilities of standard fluid bed processing for development of various dosage forms of “Multiple Unit Particulate Systems” (MUPS) with better therapeutic efficacy and economic benefits.
Keywords:
Fluid-bed Technology, Pelletization, Granulation, Agglomeration, Formulation developmentDOI
https://doi.org/10.25004/IJPSDR.2010.020403References
2. Ylirussi J, Rasanen E, Rantanen J, Mannermaa JP. The characterization of Fluidization Behavior Using a Novel Multichamber Microscale Fluid Bed. J. Pharma Sci. 2004; 3: 780-791.
3. Vuppala MK, Parikh DM, Bhagat HR. Application of powder-layering technology and film coating for manufacture of sustained-release pellets using a rotary fluid bed processor. Drug Dev Ind Pharm. 1997; 23: 687-694.
4. www.chemicalonline.com; Accessed on 15.11.2010.
5. Gu L, Liew CV, Heng PW. Wet spheronization by rotary processing: a multistage single-pot process for producing spheroids. Drug Dev Ind Pharm. 2004; 30: 111-123.
6. www.engineering.uakron.edu; Accessed on 15.11.2010.
7. Banks M, Aulton ME. Fluidized bed granulation - A Chronology. Drug Dev Ind Pharm. 1991; 17: 1437-1463.
8. Kristensen J, Schaefer T, Kleinebudde P. Direct pelletization in a rotary processor controlled by torque measurements, I: influence of process variables. Pharm Dev Technol. 2000; 5: 247-256.
9. Kristensen J, Schaefer T, Kleinebudde P. Direct pelletization in a rotary processor controlled by torque measurement, II: effect of changes in the content of microcrystalline cellulose. AAPS Pharm Sci. Tech. 2000; 2: E24.
10. Aulton ME. “Pharmaceutics: The science of dosage form design”, Edn 2, Churchill Livingstone, Edinburgh, 2002, pp. 373.
11. www.glatt.com; Accessed on 10.11.2010.
12. Kristensen J. Direct pelletization in a rotary processor controlled by torque measurements, III: investigation of microcrystalline cellulose and lactose grade. AAPS Pharm Sci Tech. 2005; 6: E495-E503.
13. Vertommen J, Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Drug Dev Ind Pharm. 1997; 23: 39-46.
14. Ansel C, Allen LV, Popovich NG. “Pharmaceutical dosage form and Drug delivery system”, Edn 8, B.I Publications, India, 2005, pp. 193, 243.
15. Swarbrick J, Boylan JC, “Fluid bed dryer, granulator and coaters”, Encyclopedia of pharmaceutical technology, Volume- 6, Marcel Dekker INC, New York, 1992, pp. 171-173.
16. Watano S, Sato Y, Miyanami K, Murakami T, Oda N. Scale-up of agitation fluidized bed granulation. Part 1: preliminary experimental approach for optimization of process variables. Chem Pharm Bull (Tokyo). 1995; 43: 1212-1216.
17. Othomer DF. Fluidization: Background, History and Future of Fluid bed systems. Reinhold publishing corporation, New York. 1956; 102-115.
18. Holm P, Bonde M, Wigmore T. Pelletization by granulation in a roto-processor RP-2. Part 1: effects of process and product variables on granule growth. Pharm Technol Eur. 1996; 8: 22-36.
19. www.cjtech.co.kr; Accessed on 10.11.2010.
20. www.kurimoto.co.jp; Accessed on 10.11.2010.
21. Jager KF, Bauer KH. Effects of material motion on agglomeration in the rotary fluidized bed granulator. Drugs Made Ger. 1982; 25: 61-65.
22. www.bepex.com; Accessed on 10.11.2010.
23. Meshram R, Bajaj A. “Solid dispersion and enteric coating of pancreatin enzyme using fluidized bed coating and other techniques” Indian Drugs. 2005; 42(12): 792-796.
24. www.wurster.net; Accessed on 10.11.2010.
25. Vazquez ER. “Optimization of drying end point measurement for the automation of Fluidized bed dryer using FT-IR Spectroscopy” M.Sc Thesis, University of Puerto Rico , Mayaguez Campus, 2004.
26. www.fritzspecialty.com; Accessed on 10.11.2010.
27. Robinson RL, Hollenbeck RG. Manufacture of spherical acetaminophen pellets: comparison of rotary processing with multiple-step extrusion and spheronization. Pharm Technol. 1991; 15: 48-56.
28. www.kurimoto.co.jp; Accessed on 12.10.2010.
29. www.drytecheng.com; Accessed on 12.10.2010.
30. Petersen FJ, Worts O, Schaefer T, Sojka PE. Effervescent atomization of aqueous polymer solutions and dispersions. Pharm Dev Technol. 2001; 6: 201-210.
31. www.eliteboilers.com; Accessed on 12.10.2010.
32. Lachman L, Lieberman HA, Kanig JL, “Granulation” , The Theory and practice of industrial pharmacy, Edn 3, Verghese Publishing House, Bombay, 1991, pp. 58-59.
33. www.glattair.com; Accessed on 15.11.2010.
34. European Pharmacopeia. Strasbourg, France: Council of Europe; 2002.
35. www.niroinc.com; Accessed on 15.11.2010.
36. www.engr.pitt.edu; Accessed on 15.11.2010.
37. www.pharmaceutical-equipment.com; Accessed on 15.11.2010.
38. Turkoglu M, Hem, Sakr A. Evaluation of rotary fluidized-bed as wet granulation equipment. Eur J Pharm Biopharm. 1995; 41: 388-394.
39. www.equipnetindia.com; Accessed on 15.11.2010.
40. www.swensontechnology.com; Accessed on 15.11.2010.
Published
Abstract Display: 1572 
PDF Downloads: 3026 
